scholarly journals Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation

Diabetologia ◽  
2021 ◽  
Author(s):  
Dario Iafusco ◽  
Angela Zanfardino ◽  
Alessia Piscopo ◽  
Francesca Casaburo ◽  
Angelica De Nigris ◽  
...  
2020 ◽  
Vol 40 (1) ◽  
pp. 56-59
Author(s):  
Sibabratta Patnaik ◽  
Bandya Sahoo ◽  
Mukesh Kumar Jain ◽  
Reshmi Mishra ◽  
Jyotiranjan Behera

Diabetes Mellitus in first six months of life is usually monogenic and is referred to as neonatal diabetes mellitus. The incidence of neonatal diabetes is extremely rare and varies from 1:89000 to 1:400000 live births. We report a two months old baby presenting with repeated seizures; on evaluation found to have diabetic ketoacidosis and initially managed with IV insulin infusion. Genetic study revealed heterozygous mutation, p. Valin 252 Leu in KCNJ 11 gene. This mutation suggests responsiveness to oral glibenclamide. The baby has responded to therapy. Seizure as a presenting feature for hyperglycemia is a rare entity


2013 ◽  
Vol 39 (4) ◽  
pp. 370-374 ◽  
Author(s):  
G. Catli ◽  
A. Abaci ◽  
S.E. Flanagan ◽  
E. De Franco ◽  
S. Ellard ◽  
...  

1999 ◽  
Vol 66 (3) ◽  
pp. 363-373 ◽  
Author(s):  
Ashraf T. Soliman ◽  
Mahmoud M. ElZalabany ◽  
Bhasker Bappal ◽  
Issa AlSalmi ◽  
Vasantha de Silva ◽  
...  

1998 ◽  
Vol 29 (3) ◽  
pp. 155-158 ◽  
Author(s):  
A. Simonati ◽  
P. Battistella ◽  
C. Guariso ◽  
M. Clementi ◽  
N. Rizzuto

Diabetologia ◽  
2002 ◽  
Vol 45 (2) ◽  
pp. 290-290 ◽  
Author(s):  
A. L. Gloyn ◽  
S. Ellard ◽  
J. P. Shield ◽  
I. K. Temple ◽  
D. J. G. Mackay ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document